Reply to: 'Validating the ALBI grade: Its current and future use in HCC prognostication'

Affiliations

¹ Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W120HS London, UK. Electronic address: david.pinato@imperial.ac.uk.
² Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W120HS London, UK.

Free article

Comment

David J Pinato et al. J Hepatol. 2017 Mar.

Free article

. 2017 Mar;66(3):663-664.

doi: 10.1016/j.jhep.2016.11.010. Epub 2016 Nov 25.

¹ Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W120HS London, UK. Electronic address: david.pinato@imperial.ac.uk.
² Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W120HS London, UK.

No abstract available

Comment on

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, Bettinger D, Jang JW, Smirne C, Kim YW, Kudo M, Howell J, Ramaswami R, Burlone ME, Guerra V, Thimme R, Ishizuka M, Stebbing J, Pirisi M, Carr BI. Pinato DJ, et al. J Hepatol. 2017 Feb;66(2):338-346. doi: 10.1016/j.jhep.2016.09.008. Epub 2016 Sep 24. J Hepatol. 2017. PMID: 27677714
Validating the ALBI grade: Its current and future use in HCC prognostication.
Chan AWH, Leung HHW, Chong CCN, Chan SL. Chan AWH, et al. J Hepatol. 2017 Mar;66(3):661-663. doi: 10.1016/j.jhep.2016.10.037. Epub 2016 Nov 25. J Hepatol. 2017. PMID: 27890792 No abstract available.